ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1921

Diagnostic Utility of Serum IgG4 in IgG4-Related Disease

Mollie Carruthers1, Tamara Augustin2, John H. Stone1 and Arezou Khosroshahi1, 1Rheumatology, Massachusetts General Hospital, Boston, MA, 2Internal Medicine, Internal Medicine, Northshore Medical Center, Salem, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Immunoglobulin (IG), serologic tests and statistical methods

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: IgG4-related disease (IgG4-RD) is a recently recognized fibro-inflammatory disease with multi-organ system involvement, often but not always characterized by elevated serum IgG4 concentrations. The aim of this study was to determine the sensitivity, specificity, and positive and negative predictive values of serum IgG4 levels for the diagnosis of IgG4-RD. 

Methods: This study was approved by the Institutional Review Board of our hospital.  We searched the Massachusetts General Hospital database using the Research Patient Data Registry tool. Since March, 2001, 193 serum samples from unique patients were found to have elevated serum IgG4 concentrations (normal < 135 mg/dL).  We reviewed the electronic medical record to determine the reason for the serum IgG4 assay and the underlying diagnosis in every case.  The diagnostic criteria of IgG4-RD were determined according to the IgG4-RD international symposium consensus guidelines.  In addition, we randomly selected 193 separate patients with normal serum IgG4 concentrations (from a pool of 3360 patients with normal results) in order to evaluate the test characteristics of IgG4 measurement.

Results: Among the 386 patients analyzed, 73 had either probable or definitive diagnoses of IgG4-RD.  Sixty-six of these 73 patients had elevated serum IgG4 concentrations (mean: 404 mg/dL), for a sensitivity of 90%.  In contrast, 313 (82%) of the patients analyzed did not have IgG4-RD diagnoses.  Among those, 127 had elevated IgG4 concentrations (mean: 232 mg/dL; p <0.0001), for a specificity of 59%.  The non-IgG4-RD diagnoses associated with elevated serum IgG4 levels are shown in the Figure. Common causes of false-positive results were chronic sinusitis, recurrent pneumonia, and connective tissue diseases such as lupus, Sjögren’s, and vasculitides. The negative predictive value of a serum IgG4 assay was 96%, but the positive predictive value was only 34%.

Conclusion: With regard to the diagnosis of IgG4-RD, both the sensitivity and the negative predictive value of serum IgG4 assays are high.  However, multiple non-IgG4-RD conditions can also be associated with elevated serum IgG4 concentrations, leading to poor specificity and a low positive predictive value for this test.

Figure: Diagnoses Associated with Elevated Serum IgG4 Concentrations


Disclosure:

M. Carruthers,
None;

T. Augustin,
None;

J. H. Stone,

Genentech,

5;

A. Khosroshahi,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-utility-of-serum-igg4-in-igg4-related-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology